The South African Health Products Regulatory Authority has approved the use of the Sinovac Covid-19 vaccine.
However, under certain conditions.
The approval is under Section 21 of the Medicines and Related Substance Act.
Individuals between the ages of 18 and 59 years can use the vaccine.
There are two doses that are administered 14 to 28 days apart.
One of the conditions is that Sinovac must submit the final results of ongoing clinical studies.
It also needs to submit periodic safety updates.
The Sinovac vaccine has a provisional shelf life of 24 months.
More Stories
Zuma Decries SCA Parole Ruling
Parliament Processing Key Recommendations Of State Capture Report
African Nations Commit To Ending AIDS In Children By 2030
Tourism Department Responds To Tottenham Hotspur Deal
Vulnerable South Africans Now Eligible For 5th COVID-19 Booster
Cape Town Mayor Urges Residents To Reduce Water Usage
Calls For State Of Disaster On Energy Crisis At ANC Lekgotla
Petrol And Diesel Prices Set To Rise
SA’s First COVID-19 jab Ready For Trials
CoCT Plans To Shield Capetonians From Power Cuts Within 3 Years – Hill-Lewis
Modernise Basic Education System – Ramaphosa
New Johannesburg Mayor To Be Elected On Friday